Brelovitug
Product Specifications
CAS Number
3033337-14-0
Target
HBV
Related Pathways
Microbiology/Virology
Bioactivity
Brelovitug (BJT-778) is a humanized IgG1 neutralizing monoclonal antibody that targets hepatitis B surface antigen (HBsAg) . It exhibits significant antiviral activity by neutralizing and clearing HBV and HDV, as well as eliminating subviral particles containing HBsAg. Brelovitug is applicable for research on HDV and HBV infections, chronic hepatitis D (CHD), and chronic hepatitis B (CHB) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx032305-01 80 µL
SEC24 Homolog C, COPII Coat Complex Component (SEC24C) Antibody
Sign In for Pricing
View Details 
abx032305-02 400 µL
SEC24 Homolog C, COPII Coat Complex Component (SEC24C) Antibody
Sign In for Pricing
View Details 
MBS6476081-01 0.2 mL
FKBP11, CT (FK506-binding Protein 11, Peptidyl-prolyl cis-trans Isomerase FKBP11, PPIase FKBP11, Rotamase, 19kD FK506-binding Protein, 19kD FKBP, FKBP-19, UNQ336/PRO535, FKBP19, FKBP-11) (Azide free) (HRP)
Sign In for Pricing
View Details MBS6476081-02 5x 0.2 mL
FKBP11, CT (FK506-binding Protein 11, Peptidyl-prolyl cis-trans Isomerase FKBP11, PPIase FKBP11, Rotamase, 19kD FK506-binding Protein, 19kD FKBP, FKBP-19, UNQ336/PRO535, FKBP19, FKBP-11) (Azide free) (HRP)
Sign In for Pricing
View Details